HNI Gian Parkash Aggarwal Sells a Rs 167 Crore Stake in Innova Captab as SBI Mutual Fund Buys In
- October 1, 2026
- Posted by: Chaitanya Auti
- Category: News
Innova Captab Rs 1,171.30, up 0.99% (1 Oct, 9:13 AM). HNI sold 2.7% for Rs 167.4 crore at Rs 1,080.04/share. SBI MF bought 1.45% at Rs 1,080/share. P/E 43.02 vs industry 38.34.
Quick Answer
The Innova Captab share price was Rs 1,171.30 at 9:13 AM on 1 October 2026, up 0.99 percent, after high-net-worth individual Gian Parkash Aggarwal sold 15.5 lakh shares, a 2.7 percent stake in the pharmaceutical company, for Rs 167.4 crore at Rs 1,080.04 apiece. SBI Mutual Fund acquired 8.33 lakh shares, representing a 1.45 percent stake, for Rs 89.99 crore at Rs 1,080 per share, taking up a portion of the shares the HNI sold. The sell side of 15.5 lakh shares was larger than SBI Mutual Fund’s 8.33 lakh share purchase, so other buyers not identified in the disclosure reviewed accounted for the remaining shares. Innova Captab trades at a P/E of 43.02 against a pharmaceutical industry average of 38.34, a modest premium.
Innova Captab Limited, a pharmaceutical manufacturer, saw a large stake sale on Tuesday when high-net-worth individual Gian Parkash Aggarwal sold 15.5 lakh shares, representing a 2.7 percent stake, for Rs 167.4 crore at Rs 1,080.04 per share. The transaction was executed well below the stock’s subsequent trading level of Rs 1,171.30, a gap of more than 8 percent.
Click Here – Get Free Investment Predictions
SBI Mutual Fund stepped in as a buyer, acquiring 8.33 lakh shares for Rs 89.99 crore, a 1.45 percent stake, at Rs 1,080 per share. This article covers the deal, the company’s valuation, and the risks behind the Innova Captab share price.
What the Innova Captab Stake Sale Shows
| Item | Detail |
|---|---|
| Seller | HNI Gian Parkash Aggarwal |
| Shares sold | 15.5 lakh (2.7% stake) |
| Value | Rs 167.4 crore |
| Buyer | SBI Mutual Fund |
| Shares bought | 8.33 lakh (1.45% stake) |
| Value | Rs 89.99 crore |
| Price | Rs 1,080 to Rs 1,080.04 per share |
The transaction price of Rs 1,080 was notably below where Innova Captab subsequently traded at Rs 1,171.30, which can happen in block deals executed at a discount to secure a buyer for a large quantity of shares in one transaction rather than through gradual open-market sales that could pressure the price further.
Also read – Stocks to Watch Today: Alicon Castalloy Jumps 20%, Ircon and Rites Surge on Heavy Volume
Innova Captab Share Price Today: Numbers and Technical Levels
| Metric | Value (1 Oct, 9:13 AM) |
|---|---|
| Innova Captab share price | Rs 1,171.30 (up 0.99%) |
| Previous close | Rs 1,159.80 |
| 52-week high / low | Rs 1,353.50 / Rs 622.00 |
| RSI (14-day) | 50.6 |
| SuperTrend | Bullish, support at Rs 1,119.73 |
| 20-day average | Rs 1,195.78 |
| Market cap | Rs 6,628 crore |
| P/E vs industry P/E | 43.02 vs 38.34 |
| Dividend yield | 0.17% |
The Innova Captab share price is 13.5 percent below its 52-week high of Rs 1,353.50 and sits just below its 20-day average of Rs 1,195.78, with a neutral RSI of 50.6. The SuperTrend indicator remains bullish with support at Rs 1,119.73.
Compare Pharma Stocks and Live Levels on the Univest Screener
Valuation Behind the Innova Captab Share Price
Innova Captab trades at a P/E of 43.02 against a pharmaceutical industry average of 38.34, a modest premium. Return on equity of 12.92 percent and debt to equity of 0.32 are reasonable for a mid-sized pharmaceutical manufacturer.
Risks for the Innova Captab Share Price
The discounted block deal price is a reminder that large shareholders can exit at levels below the prevailing market price when liquidity for a sizeable stake is needed quickly, which can weigh on sentiment if repeated. Pharmaceutical pricing and regulatory risk, including drug pricing controls and quality compliance requirements, is a structural factor for the sector. Customer and product concentration risk, common for mid-sized pharma manufacturers, is the third factor to watch.
Download the Univest iOS App or Univest Android App to track the Innova Captab share price and get alerts on block deals.
Conclusion
The Innova Captab share price rose even as an HNI sold a Rs 167 crore stake at a discount to the market price, with SBI Mutual Fund among the buyers stepping in. A modest valuation premium to the pharma industry and a bullish technical trend are supports, while the discounted block deal and sector regulatory risk are the concerns. Investors deciding whether to buy Innova Captab shares should watch the Rs 1,195.78 average as resistance, follow stop-loss levels and consult a SEBI-registered adviser.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data independently before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
What is the Innova Captab share price today?
Ans. The Innova Captab share price was Rs 1,171.30 at 9:13 AM on 1 October 2026, up 0.99 percent from Rs 1,159.80.
Who sold shares in Innova Captab?
Ans. HNI Gian Parkash Aggarwal sold 15.5 lakh shares, a 2.7 percent stake, for Rs 167.4 crore at Rs 1,080.04 per share.
Who bought shares in Innova Captab?
Ans. SBI Mutual Fund acquired 8.33 lakh shares, a 1.45 percent stake, for Rs 89.99 crore at Rs 1,080 per share.
Why was the Innova Captab block deal priced below the market price?
Ans. Block deals are often priced at a discount to secure a buyer for a large quantity of shares in one transaction, and the Rs 1,080 price was notably below the subsequent trading level of Rs 1,171.30.
Is the Innova Captab share price expensive?
Ans. The P/E of 43.02 is a modest premium to the pharmaceutical industry average of 38.34.
What are the key technical levels for the Innova Captab share price?
Ans. The key levels are SuperTrend support at Rs 1,119.73 and the 20-day average of Rs 1,195.78. The RSI is 50.6.
What does Innova Captab manufacture?
Ans. It is a pharmaceutical manufacturer; the specific disclosures reviewed did not detail its full product portfolio.
Should I buy Innova Captab shares now?
Ans. Institutional buying from SBI Mutual Fund is a positive sign, but the discounted block deal is worth noting. Use a stop-loss and consult a SEBI-registered adviser.